theMednetRegister

Dermatology

Allergy & Immunology   

Questions discussed in this category

Are there any contraindications to starting a patient on Dupixent for prurigo nodularis if the patient is already on Xolair for asthma?
1 Answer available
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
2 Answers available
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
1 Answer available
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
2 Answers available
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
1 Answer available
Do you utilize AIT for atopic dermatitis if there is no AR present?
4 Answers available
How do you reassure families that no allergy testing is needed for urticaria?
2 Answers available
How do you approach treating patients who develop psoriasis while on Dupixent?
Do you start/trial them on another biologic or just rely on topical therapies?
1 Answer available
What is your experience managing patients with chronic spontaneous urticaria occurring only at night?
Female in her early 40s with chronic spontaneous urticaria occurring consistently only at night for the past 4 years. Lesions develop only at night wh...
1 Answer available
How does omalizumab play a role in the armamentarium of atopic dermatitis?
1 Answer available
How do you approach work up for underlying rheumatologic disease in patients referred for chronic urticaria?
2 Answers available
What treatments do you consider for cholinergic urticaria refractory to high dose H1 blockers and omalizumab?
1 Answer available
How do you approach patients that develop atopic dermatitis while on biologics for psoriasis?
I have an elderly patient with a history of biopsy-proven psoriasis on IL-17 biologic therapy. She has developed an intense itch without a primary ras...
1 Answer available
How do you manage atopic dermatitis in pediatric patients who has failed dupilumab?
(preschool-aged patients)
1 Answer available
How would you work up a patient with cutaneous mastocytosis?
Is a BM biopsy a must when there is skin involvement? If tryptase level is mildly elevated but less than 20 would you recommend a BM biopsy?
1 Answer available
Do you have to remove gold dental crowns if patch testing reveals a gold allergy?
1 Answer available
Do you prescribe fluocinolone in peanut oil in patients with peanut allergies?
3 Answers available
How do you perform patch testing in patients who are allergic to adhesives?
1 Answer available
How do you manage recurrent urticarial lesions in a patient with underlying connective tissue disease that is otherwise well-controlled?
3 Answers available
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available
Does Dupixent interfere with patch testing?
1 Answer available
How do you counsel parents of children with atopic dermatitis about preventing recurrent Staph infections?
Are dilute bleach baths enough? Should they use any topical therapies? Is there a need for Staph decolonization with something like mupirocin?
1 Answer available
When do you refer pediatric patients with eczema to an allergist?
Are there cases where food or environmental allergies significantly worsen eczema in children?
1 Answer available
With the approval of oral JAK inhibitors such as Upadacitinib for atopic dermatitis, how are you considering its safety profile in comparison to traditional immunosuppressants such as prednisone, methotrexate, azathioprine, and mycophenolate?
Especially in the setting of these being more narrow acting than tofacitinib, should we consider them safer than our old drugs?
2 Answers available
What is your approach to treating patients with dupilumab induced facial redness?
2 Answers available
Do you avoid dupilumab (IL-4 inhibition) for severe asthma in patients already taking a biologic agent for RA?
1 Answer available
What is your preferred regimen for remission induction and maintenance in EGPA with cardiac involvement?
1 Answer available
Is it okay to use medications associated with drug-induced lupus in patients with SLE?
1 Answer available
How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available
Which ANCA vasculitis patients are better candidates for cyclophosphamide rather than rituximab?
2 Answers available
How does your treatment algorithm differ for drug-induced ANCA vasculitis compared to non drug-induced ANCA vasculitis in cases with severe/organ-threatening manifestations?
1 Answer available


Papers discussed in this category

The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Medicine (Baltimore),
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
The New England journal of medicine, 2010-07-15
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
Eur J Dermatol,
Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023 Feb 11
Eczematized psoriasis - a frequent but often neglected variant of plaque psoriasis.
The Journal of allergy and clinical immunology, 2012 Feb 14
Chronic urticaria and autoimmunity: associations found in a large population study.
Journal of the American Academy of Dermatology, 2003-04
Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive.
Arthritis & rheumatology (Hoboken, N.J.), 2023 Jul 24
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Allergy, 2021 Oct 20
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Allergy, asthma & immunology research, 2020 Sep
Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea.
The journal of allergy and clinical immunology. In practice, 2018 Jul-Aug
How to Approach Chronic Inducible Urticaria.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009 Nov 23
Recommendations for performing and evaluating the results of the minor test according to a sweating intensity visual scale.
American journal of clinical dermatology, 2022 Sep 15
Cholinergic Urticaria: Subtype Classification and Clinical Approach.
The Journal of allergy and clinical immunology, 2022 Sep 30
Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023 Dec 18
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2019 Feb 04
Omalizumab for atopic dermatitis: evidence for and against its use.
The Journal of allergy and clinical immunology, 2016 Jul 14
Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis.
JAMA pediatrics, 2020 Jan 01
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1995-02
Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.
The journal of allergy and clinical immunology. In practice, 2021 Mar
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
The journal of allergy and clinical immunology. In practice, 2021 Apr 20
The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and Why.
The journal of allergy and clinical immunology. In practice, 2020 Mar 13
Delayed Pressure Urticaria: A Systematic Review of Treatment Options.

Related Topics in Dermatology

Copyright © 2024 theMednet
All Rights Reserved.